Home > Healthcare > Takotsubo Syndrome Therapeutics Market > Table of Contents

Takotsubo Syndrome Therapeutics Market - By Therapy (DAPT, Anticoagulants, Beta-blockers, Statins, Diuretics, ACE Inhibitors), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital, Retail Pharmacies), Global Forecast, (2022 – 2032)

  • Report ID: GMI6535
  • Published Date: Aug 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Base estimates & calculations

1.3    Forecast parameters

1.4    COVID-19 impact analysis at global level

1.5    Data validation

1.6    Data Sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1   Paid sources

1.6.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Global takotsubo syndrome therapeutics market 360synopsis, 2018 - 2032

2.1.1    Business trends

2.1.2    Regional trends

2.1.3    Therapy trends

2.1.4    Route of administration trends

2.1.5    Distribution channel trends

Chapter 3   Takotsubo Syndrome Therapeutics Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Increasing geriatric population

3.2.1.2   Advancements in diagnostic techniques

3.2.1.3   Advances in personalized medicine and tailored treatment

3.2.1.4   Increasing prevalence of cardiovascular diseases

3.2.2    Industry pitfalls & challenges

3.2.2.1   Limited understanding of underlying mechanisms behind takotsubo syndrome

3.2.2.2   Lack of specific treatment guidelines

3.2.2.3   High cost of treatment

3.3    Growth potential analysis

3.3.1    By therapy

3.3.2    By route of administration

3.3.3    By distribution channel

3.4    COVID- 19 impact analysis

3.5    Regulatory landscape

3.6    Technology landscape

3.7    Porter's analysis

3.8    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis, 2022

4.3    Company positioning matrix

4.4    Competitive analysis of major market players

4.5    Strategic outlook matrix

Chapter 5   Takotsubo Syndrome Therapeutics Market Size and Forecast, By Therapy (USD Million)

5.1    Key trends, by therapy

5.2    Dual antiplatelet therapy (DAPT)

5.3    Anticoagulants

5.4    Beta-blockers

5.5    Angiotensin-converting enzyme (ACE) inhibitors

5.6    Aldosterone receptor blockers

5.7    Statins

5.8    Diuretics

Chapter 6   Takotsubo Syndrome Therapeutics Market Size and Forecast, By Route of Administration (USD Million)

6.1    Key trends, by route of administration

6.2    Oral

6.3    Parenteral

Chapter 7   Takotsubo Syndrome Therapeutics Market Size and Forecast, By Distribution Channel (USD Million)

7.1    Key trends, by distribution channel

7.2    Hospital pharmacies

7.3    Retail pharmacies/ drug stores

7.4    Other distribution channels

Chapter 8   Takotsubo Syndrome Therapeutics Market Size and Forecast, By Region (USD Million)

8.1    Key trends, by region

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Spain

8.3.5    Italy

8.3.6    Rest of Europe

8.4    Asia Pacific

8.4.1    Japan

8.4.2    China

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Rest of Asia Pacific

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Rest of Latin America

8.6    Middle East & Africa

8.6.1    South Africa

8.6.2    Saudi Arabia

8.6.3    Rest of Middle East & Africa

Chapter 9   Company Profiles

9.1    Sanofi SA

9.2    Pfizer Inc.

9.3    AbbVie Inc.

9.4    ANI Pharmaceuticals, Inc.

9.5    Novartis AG

9.6    GlaxoSmithKline plc

9.7    Taro Pharmaceutical Industries Ltd.

9.8    Amneal Pharmaceuticals LLC.

9.9    Teva Pharmaceutical Industries Ltd.

9.10    Sun Pharmaceutical Industries Ltd.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 135
  • Countries covered: 22
  • Pages: 200
 Download Free Sample